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Purpose. To study the contribution of a novel PAF receptor antagonist LAU-0901 in the modulation of the increased inﬂammatory
response in mice exposed to dessicating conditions (DE) after PRK. Methods. Eighty 13-14 week old female Balb/C mice were
used. They were divided into two groups: One group was treated with LAU-0901 topical drops. The other group was treated with
vehicle. In each group ten mice served as controls and ten were placed in DE. The other twenty mice underwent bilateral PRK
and were divided in two additional groups: ten mice remained under normal conditions (NC) and the other ten were exposed
to DE. After 1 week all animals underwent in vivo confocal microscopy, immunostaining and western blotting analysis. Results.
Confocal microscopy showed an increased number of reﬂective structures in the corneal epithelium after PRK and exposure to DE
in eyes treated with vehicle as compared to eyes treated with LAU-0901. Signiﬁcant decrease of COX-2 and Arginase I expression
and reduced alpha SMA cells was observed after PRK and exposure to DE in eyes treated with LAU-0901. Discussion: Exposure of
mice to a DE after PRK increases the epithelial turnover rate. PAF is involved in the inﬂammatory cell inﬁltration and expression
of inﬂammatory cytokines that follow PRK under DE.
Copyright © 2009 Salomon Esquenazi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Following PRK, the corneal healing process is initiated after
theepithelialinjurythroughthereleaseofmultiplecytokines
and growth factors such as IL-1, TNFα,E G F ,a n dP D G F .
The initial insult induces keratocyte apoptosis and necrosis
[1]. Myoﬁbroblasts appear in the subepithelial stroma 1-2
weeks after the injury or surgery, presumably derived from
keratocytes under the inﬂuence of TGF-β [2]. Abundant
inﬂammatory cells including monocytes, granulocytes, and
lymphocytesbegintoappearinthecornealstromasoonafter
an injury or surgery [3]. Previous studies have shown that
PAF is a potent inﬂammatory mediator in the cornea that
acts through speciﬁc receptors and stimulates cell inﬁltration
and expression of cyclooxygenaese-2 (COX-2) [1]. We have
demonstrated that there is an increase in inﬂammatory cell
inﬁltration and COX-2 expression in mice corneas exposed
to desiccating environment (DE) following PRK [4]. Possible
contributionstothewoundhealingprocessareyetunknown;
however, clinical studies have shown that dry eye conditions
after LASIK produce long-term regression of the refractive
results [5]. The present work studies the contribution of a
novel PAF receptor antagonist LAU-0901 in the modulation
of the increased inﬂammatory response in mice exposed to
DE after PRK.
2. Methods
2.1. Animal Model. Eighty 13-14-week-old female Balb/C
micewereused.Beforesurgeryorinvivoconfocalevaluation
they were all examined using slit-lamp and ﬂuorescein to
assess the ocular surface integrity. The animals were treated
according to the Resolution of human use of animals in
Vision Research approved by the Association for Research2 Clinical and Developmental Immunology
in Vision and Ophthalmology, and the experimental pro-
tocol was approved by the institutional animal care and
use committee, Louisiana State University Health Sciences
Center. Animals were anesthetized intramuscularly with
2mg/kg body weight of Xylazine and 50mg/kg body weight
of ketamine. They were divided in two groups. One group
was treated with LAU-0901 topical drops 4 times a day for 1
week. The other group was treated with vehicle. From each
group ten mice served as controls and ten were placed in DE
created by placing the animals between two fans to obtain
a continuous airﬂow of 15L/min, in a room at 22◦Cw i t ha
relative humidity of 25%. Topical atropine 1% was applied
twice a week for 2 weeks. The other twenty mice underwent
bilateralcornealscrapingusinganelectricbrush(Algerbrush
II, Alger Co, Lago Vista CA) involving the entire cornea
without compromising the limbal area.. The animals were
then divided in two additional groups: ten mice were placed
in normal conditions (NC) and the other ten were exposed
to DE.
2.2. In Vivo Confocal Microscopy. A Heidelberg retina
tomography (HRT) II/Rostock Corneal Module (Heidelberg
Engineering GmbH, Heidelberg, Germany) was used to
examine the animals. Mice were anesthetized as explained
previously and placed in a modiﬁed 50mL centrifugation
t u b e sm o u n t e do nat e s tt u b eh o l d e ra sd e s c r i b e de a r l i e r
[4]. The HRT II camera was left connected to the head
rest in a horizontal position. The laser source was a diode
laser with a wavelength of 670nm and the objective of
the microscope is an immersion lens, magniﬁcation x60,
numerical aperture 0.90 (Olympus, Hamburg, Germany). A
drop of genteal gel (Novartis, St. Louis, MO) was placed on
the tip of the objective lens to maintain immersion contact
between the objective lens and the eye. Images covering
an area of 400 × 400μm with transverse optical resolution
of approximately 1μm/pixel were taken. Oblique sections
of the cornea were obtained by controlling manually the
x-y position and the depth of the optical section. For all
eyes 20 confocal microscopy images of each layer including
the superﬁcial and basal epithelium, anterior and posterior
stroma and endothelium were recorded. The images were
then analyzed qualitatively and quantitatively and compared
between the two groups.
2.3. Quantiﬁcation of Cells and Nerves. Superﬁcial and basal
epithelial, anterior and posterior stromal and endothelial
cell densities were measured using the program associated
with the HRT II/RCM as described earlier [4]. Finally, the
number of marks was counted by the computer and cellular
densities were expressed as cells per mm2. The results were
collected in a computer spread sheet (Excel 2000; Microsoft
Corp., Redmond, WA). Statistical diﬀerences were calculated
using the Statistical Program for Social Sciences (SPSS for
Windows, ver 9.0; SPSS Sciences, Chicago, IL).
2.4. Immunoﬂuorescence Staining. T h em i c ew e r eh u m a n e l y
euthanized and the eyes were immediately enucleated. Cryo-
stat sections 8μm were prepared from each eyeball. After
ﬁxing, the sections were incubated with CD45, GR-1, CD
11b CD-11c, COX-2, Arginase II, and alpha-SMA antibodies
overnight at 4◦C. The sections were incubated with goat
antirabbit IgG FITC-conjugated secondary antibody for 1
hour at room temperature. DAPI staining was performed
to localize the nuclei. Sections were examined with a
ﬂuorescence microscope, and images were recorded with a
digital camera.
2.5. Western Blot Analysis. Corneas were isolated and
digested with 0.3% collagenease A to obtain the cells. Cells
were homogenized in 50mM Tris-HCl (pH 7.5), 1mM
EDTA, 1mM EGTA, 0.5mM sodium orthovanadate, 1mM
dithiothreitol (DTT), 1% Triton X-100, 5mM sodium ﬂuo-
ride, 1mM sodium pyrophosphate, 150mM NaCl, 10mM
sodium β-glycerophosphate, 1mM phenylmethylsulfonyl
ﬂuoride(PMSF),1μg/mLaprotininandleupeptin,and1μM
microcystin (lysis buﬀer). The homogenate was centrifuged
at 12 000rpm for 15 minutes, and total protein was deter-
mined as the supernatant. All procedures were performed
at 4◦C. Samples were resolved by SDS-polyacrylamide gel
electrophoresis (9%–12% gel) and transferred to polyvinyli-
dene diﬂuoride (PVDF) membranes (Amersham Pharmacia
Biotech, Piscataway, NJ). Biotinylated protein molecular
weight standards were applied in one lane of each gel.
The nonspeciﬁc proteins were blocked with 5% nonfat
milk in Tris-buﬀered saline (TBS, 20mM Tris-HCl, 150mM
NaCl [pH 7.6]) plus 0.1% Tween-20 for 1 hour and
then probed with various primary antibodies, as described
in the experiments for 2 hours at room temperature or
overnight at 4◦C. The membranes were washed six times
with TBS plus 0.1% Tween-20 and further incubated with
HRP-conjugated secondary antibodies. Protein bands were
visualized using chemiluminescence detection reagents (ECL
Plus; Amersham) and exposed to FUJIFILM LAS- 3000
system.
3. Results
3.1. In Vivo Confocal Microscopy. Images of corneal epithe-
lium in mice after PRK and exposure to desiccating
environment with and without treatment with LAU-0901
were analyzed using in vivo confocal microscopy method
described previously [4]. Superﬁcial epithelial cells showed a
polygonal shape with hyperreﬂective nuclei surrounded by a
hyporeﬂective area. The cytoplasm was more hyperreﬂective
in the DE eyes compared with the NC corneas.
Increased number of reﬂective structures was observed
in the corneal epithelium after PRK and exposure to DE in
eyes treated with vehicle as compared with eyes treated with
LAU-0901 (743±128 cells/mm2 versus 421±109 cells/mm2)
which was statistically signiﬁcant (Mann-Whitney U test;
P = .05) (Figure 1). Basal cells appeared as dark cells with
hyperreﬂective boundaries smaller than superﬁcial cells and
very closely organized. Its density was 746 ± 176 cells/mm2
in controls, 886 ± 168 cells/mm2 after PRK and DE in eyes
treated with LAU-0901 and 1498±293 cells/mm2 in the PRK
and DE group treated with vehicle. There was a statisticallyClinical and Developmental Immunology 3
Confocal images of epithelial surface of mice treated with the PAF receptor antagonist LAU-0901
Control
PRK PRK + DE
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Figure 1: In vivo confocal microscopy images of corneal epithelium in mice after PRK and exposure to desiccating environment with and
without treatment with LAU-0901. Increased number of reﬂective structures was observed in the corneal epithelium after PRK and exposure
to DE in eyes treated with vehicle as compared with eyes treated with LAU-0901 (743 ± 128cells/mm2 versus 421 ± 109cells/mm2). The
increase in the number of reﬂective bodies was more signiﬁcant in the vehicle group compared with LAU-0901 treated eyes.
signiﬁcantincreaseinthecellcountinthegrouptreatedwith
vehicle compared with LAU-0901 (Mann-Whitney U test;
P<. 05).
3.2. Immunostainning Studies. Signiﬁcant decrease of COX-
2 expression after 1 week of PRK and exposure to desiccating
conditions in eyes treated with LAU-0901 was observed
compared with non treated eyes and controls (Figure 2).
Additionally,signiﬁcantdecreaseofArginaseIexpression
inmicecorneas1weekafterPRKandexposuretodesiccating
conditions after treatment with LAU-0901 was observed
(Figure 3).
Analysis of alpha-SMA positive cells expression showed
signiﬁcantreductioninmicecorneasafterPRKandexposure
to desiccating environment and treatment with LAU-0901,
one week postoperatively (Figure 4).
4. Discussion
Exposure of mice to a desiccating environment after PRK
increases the epithelial turnover and induces higher number
of refractive structures in the stroma. A previous study per-
formedatour laboratorydemonstrateda reducednumber of
superﬁcial and an increased number of basal epithelial cells
indicating a higher epithelial turnover in DE conditions and
high metabolic activity [4].
The increased number of cellular bodies found in the
stroma corresponds to inﬂammatory cell inﬁltration and
activated keratocytes (ﬁbroblasts and myoﬁbroblasts) that
may have been activated by the epithelial injury. Eight to
24 hours after an epithelial injury, chemokines released by
the epithelium and produced by the keratocytes in response
to cytokine stimulation attract inﬂammatory cells such
as polimorphonuclear leukocytes, macrophages/monocytes,
and T cells into the stroma from the limbal vessels and
possibly from the tears [6]. The main function of these cells
is the phagocytosis of apoptotic bodies and residual necrotic
cellular fragments. The DE may cause additional epithelial
cell damage that increases the liberation of proinﬂammatory
cytokines such as IL-1, TNF-α,a n dT G F - β inducing an
increased activation of keratocytes in the corneal stroma.
Many of the proinﬂammatory chemokines that induce a
greater inﬂux of inﬂammatory cells such as granulocyte
colony-stimulating factor (G-CSF), neutrophil activating
peptide (ENA-78), monocyte-derived neutrophil chemo-
tactic factor (MDNCF), and monocyte chemotactic and
activating factor (MCAF) have an upregulated expression in
activated keratocytes [7].4 Clinical and Developmental Immunology
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Figure 2: Signiﬁcant decrease of COX-2 expression one week after PRK and exposure to desiccating conditions (DEs) in eyes treated with
LAU-0901.
A very important inﬂammatory mediator released after
corneal injury is PAF [8]. The action of PAF is mediated by
speciﬁc receptors whose expression is enhanced after injury
[9]. During PRK, the injured epithelium releases PAF in
the area adjacent to the anterior stroma and in the lamellar
interface and triggers an inﬂammatory reaction and induces
keratocyte apoptosis and activation of distant keratocytes
and transformation to myoﬁbroblasts. Keratocyte apoptosis
that occurs in response to the epithelial injury associated
with PRK is one of the main initiators of the corneal
wound healing response [10, 11]. Our results suggest that
PAF is involved in the inﬂammatory cell inﬁltration and
expression of inﬂammatory cytokines that follow PRK under
DE. Treatment with PAF receptor antagonist (LAU-0901)
resulted in reduced expression of inﬂammatory mediators
suchasCOX-2andASEinthecornealstromacomparedwith
vehicle.
Elevated expression of ASE and Cox-2 in mice after
PRK and exposed to a desiccating environment may play
a role in the healing response. It is possible that the
monocytes use the arginine-ornithine pathway to repair
the damage caused by the inﬂammatory response after
surgery. Expression of NO synthase creates a cytotoxic
environment that may be important in the early phase of
wound healing [12]. In the early stages arginine can be
metabolized by inﬂammatory cells through the oxidative 1-
arginine deiminase that results in the formation of citrulline
and reactive nitrogen intermediates [13]. These compounds
may mediate some of the events characteristic of early
inﬂammation. As wound healing progresses, increased ASE
activity increases the catabolism of arginine and produces an
environmentfavorableforﬁbroblastreplication andcollagen
production.Clinical and Developmental Immunology 5
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Figure 3: Signiﬁcant decrease of Arginase I expression in mice corneas 1 week after PRK and exposure to desiccating conditions after
treatment with LAU-0901.
The inﬂammatory response induced by PRK pro-
duces keratocyte apoptosis. The keratocytes adjacent in
the tissue proliferate and migrate to the injured site and
undergo ﬁbroblast and myoﬁbroblast transformation. The
myoﬁbroblast—a specialized contractile ﬁbroblast—has an
important role in establishing tension during wound healing
and pathological contracture. Diﬀerentiated myoﬁbroblasts
lay down collagen, chondroitin sulfate, and other ECM
components and produce proteases. Myoﬁbroblasts express
PAF receptors [14] and this cytokine induces the synthesis
of MMPs [15]. Once the wound closes and the basal mem-
brane regenerates, the myoﬁbroblasts disappear, probably by
apoptosis. However, if they persist and continue to remodel
theECM,theprocessresultsinconnectivetissuecontraction,
scar formation, induced irregular astigmatism and abnormal
epithelial healing, and possibly stromalnecrosis and melting.
Our results demonstrated that blocking the inﬂammatory
cascade with LAU-0901 during the ﬁrst postoperatively after
PRK reduces degeneration of myoﬁbroblasts in the corneal
stromawhichmayimprovethepredictabilityoftherefractive
results after surgery.
Because the corneal wound healing response is so
complex, it is diﬃcult to intervene at more advanced steps
in the process. Instead, blocking the initial inﬂammatory
cell inﬁltration response is the most eﬀective approach.
The interaction between the overlying epithelium and the6 Clinical and Developmental Immunology
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Figure 4: Reduced expression of alpha-SMA cells in mice corneas after PRK and exposure to desiccating environment and treatment with
LAU-0901, one week postoperatively COX-2 after PRK and Dry Eye in mice corneas.
keratocyte cells and the continuing communication between
the two are key factors that lead to the successful outcome of
the healing response. Manipulating the initial inﬂammatory
cell inﬁltration with LAU-0901 may aﬀect the corneal
wound healing response and may have implications in the
predictability and stability of the refractive results after PRK.
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